Aluminum phosphate

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Aluminium phosphate
A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AB Aluminium compounds
Discover more medicines within A02AB03

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: AlO₄P
Molecular mass: 121.953 g/mol

External identifiers

CAS Substance: 7784-30-7
DrugBank Drug: DB14517
PubChem Compound: 64655
RxNorm Ingredient: 17618
SNOMED-CT Concept: 14461006
Aluminium phosphate (substance)
UNII Identifier: F92V3S521O
ALUMINUM PHOSPHATE

Medicines

Aluminum phosphate is an active ingredient of these brands:

Austria (AT)

  • (combination) REPEVAX as Adsorbed purified fimbrial Agglutinogens 2+3 (FIM)

France (FR)

Ireland (IE)

  • (combination) REPEVAX as Adsorbed purified fimbrial Agglutinogens 2+3 (FIM)

Malta (MT)

  • (combination) REPEVAX as Adsorbed purified fimbrial Agglutinogens 2+3 (FIM)

United Kingdom (UK)

  • (combination) REPEVAX as Adsorbed purified fimbrial Agglutinogens 2+3 (FIM)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.